Search Results
Slidesets
New delivery systems and long acting antiretroviral drugs- David Back, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Long-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon Walmsley
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Long COVID (Post-Acute COVID-19 Syndrome) - Susan Swindels, MBBS
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
HBsAg Loss. A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
AB 10 Anticoagulant and Antiviral Therapy in Long COVID_Johan van Weyenbergh
Presented at:
Demystifying Long COVID International Conference 2024
Slidesets
Clinical Pharmacology Long Acting ARVs - Marta Boffito, MD, PhD, FRCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
The Future of Long-acting ARV for HIV Prevention and Treatment in Europe_Jürgen Rockstroh
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2024
Slidesets
Jean-Michel Molina - Update on Long Acting Therapeutic Options for HIV Treatment
Presented at:
Chinese HIV Clinical Forum 2022
Abstracts
Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results
R. D'Amico
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Long acting HIV drugs for prevention: what are the data?- Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2018